从劳动力多元化到关键文化能力战略，以消除全国阿片类药物治疗结果的种族差异-猫眼课题宝

从劳动力多元化到关键文化能力战略，以消除全国阿片类药物治疗结果的种族差异

批准号：

10531895

负责人：

Erick Guerrero

金额：

$58.28万

依托单位：

TEXAS A&M UNIVERSITY

依托单位国家：

美国

项目类别：

财政年份：

2020

资助国家：

美国

项目状态：

未结题

起止时间：

2020-12-01 至 2025-11-30

来源：

https://reporter.nih.gov/project-details/10531895

关键词：

Address Affect African American Aftercare Buprenorphine Characteristics Client Competence Data Data Set Decision Making Dependence Disparity Dose Drug abuse Health Disparities Research Health Personnel Health Services Accessibility Hispanic Hispanic Populations Improve Access Knowledge Linguistics Link Maintenance Measurement Measures Medicaid Methadone Minority Groups Modeling Naltrexone Opioid Organizational Culture Pharmaceutical Preparations Policy Maker Process Process Measure Professional counselor Property Psychometrics Public Health Quality of Care Race Recording of previous events Recovery Research Resources Respondent Role Sampling Services Source Substance Use Disorder Surveys System Testing Treatment outcome Variant Wait Time Woman Work access disparities cultural competence disparity elimination disparity reduction dosage ethnic disparity ethnic diversity ethnic minority ethnic minority population evidence base improved instrument medication-assisted treatment minority health minority health disparity minority patient opioid epidemic opioid treatment program opioid use disorder payment programs racial disparity racial diversity racial minority racial minority population response social culture standard measure substance use treatment theories treatment disparity treatment program

项目摘要

项目成果

Erick Guerrero的其他基金

相似基金

相关文献

中文摘要

翻译

项目总结/摘要响应PAR-18-747，应对阿片类药物流行在少数民族健康和健康方面的挑战在美国的差异研究（R 01），这项研究旨在确定文化能力的作用，战略，特别是劳动力的多样性，以改善治疗的可及性，参与和药物- 辅助治疗（MAT）维持剂量，即，美沙酮、丁丙诺啡和纳洛酮，美国和西班牙裔人口在全国范围内的阿片类药物治疗计划（OTP）。这项研究将依赖于国家药物滥用治疗系统调查，这是一项独特的、具有全国代表性的纵向数据（2005-2017年）;该研究还将在2021年和2023年收集两波新数据，以评估文化和语言上适当的服务对检察官办公室程序措施的影响[等待时间，保留和适当的MAT剂量）。本研究旨在改善文化能力的测量使用黄金标准工具-文化能力组织评估（COA 360 [CLAS]），评估其对2021年和2023年过程测量的预测有效性。研究结果将为治疗方案提供信息。使用文化能力战略，以改善OTP等待时间、保留率和适当剂量，这些努力减少了类阿片使用障碍治疗中的种族/族裔差异。决策者将能够就如何分配解决阿片类药物流行所需的稀缺资源作出决定。

英文摘要

PROJECT SUMMARY/ABSTRACT In response to PAR-18-747, Addressing the Challenges of the Opioid Epidemic in Minority Health and Health Disparities Research in the U.S. (R01), this study seeks to determine the role of culturally competent strategies, and in particular workforce diversity, to improve treatment access, engagement, and medication- assisted treatment (MAT) maintenance dosage, i.e., methadone, buprenorphine and naltrexone for African- American and Hispanic populations in opioid treatment programs (OTP) nationwide. The study will rely on the National Drug Abuse Treatment System Survey (NDATSS), which is a unique, nationally representative longitudinal data (2005-2017); the study also will collect two waves of new data in 2021 and 2023 to assess the effect of culturally and linguistically appropriate services (CLAS) on OTP process measures [wait time, retention, and adequate MAT dosages). The study seeks to improve measurement of cultural competence using a gold standard instrument - the Cultural Competency Organizational Assessment (COA360 [CLAS]) and assess its predictive validity on process measures in 2021 and 2023. Findings will inform treatment programs’ use of cultural competency strategies to improve OTP wait time, retention and adequate dosage, and with these efforts reduce racial/ethnic disparities in opioid use disorder treatment. Policy-makers will be able to make decisions about how to allocate scarce resources needed to address the opioid epidemic.

期刊论文(0)

专著(0)

科研奖励(0)

会议论文